Non-infectious Dacryoadenitis.
Singh S, Selva D.
Surv Ophthalmol. 2022 Mar-Apr;67(2):353-368. doi: 10.1016/j.survophthal.2021.05.011. Epub 2021 May 31.
Infectious Dacryoadenitis: A Comprehensive Review.
Wai KM, Wolkow N, Yoon MK.
Int Ophthalmol Clin. 2022 Apr 1;62(2):71-86. doi: 10.1097/IIO.0000000000000412.
The many facets of dacryoadenitis.
Mombaerts I.
Curr Opin Ophthalmol. 2015 Jul;26(5):399-407. doi: 10.1097/ICU.0000000000000183.
SLE dacryoadenitis.
Hung YC, Wang DD, Han LSM, Betts TD, Weatherhead RG.
Orbit. 2019 Aug;38(4):338-341. doi: 10.1080/01676830.2018.1518463. Epub 2018 Dec 12.
Bilateral tuberculous dacryoadenitis.
Ayari R, Amri R, Chalbi E, Sbai MA.
Int J Mycobacteriol. 2020 Jul-Sep;9(3):332-334. doi: 10.4103/ijmy.ijmy_57_20.
Mesenchymal stem cells for treating autoimmune dacryoadenitis.
Lu X, Wang X, Nian H, Yang D, Wei R.
Stem Cell Res Ther. 2017 Jun 5;8(1):126. doi: 10.1186/s13287-017-0593-3.
Dacryoadenitis post COVID-19 infection and immunization.
Singh S, Gandhi A, Das S.
Indian J Ophthalmol. 2023 Aug;71(8):3100-3102. doi: 10.4103/IJO.IJO_30_23.
Dacryoadenitis and extraocular muscle inflammation associated with contact lens-related Acanthamoeba keratitis: A case report and review of the literature.
Sengor T, Yuzbasioglu E, Aydın Kurna S, Irkec M, Altun A, Kökcen K, Yalcin NG.
Orbit. 2017 Feb;36(1):43-47. doi: 10.1080/01676830.2016.1243132. Epub 2016 Nov 22.
Dacryoadenitis in giant cell arteritis.
Meurisse PL, Eid L, Rousseau A.
J Fr Ophtalmol. 2022 Sep;45(7):829-830. doi: 10.1016/j.jfo.2021.11.020. Epub 2022 Jun 24.
Systemic eosinophilic disease presenting as dacryoadenitis.
Danesh K, Cohen LM, Liu Y, Karlin JN, Rootman DB.
Orbit. 2023 Feb;42(1):107-111. doi: 10.1080/01676830.2021.1973514. Epub 2021 Sep 12.
